haloperidol has been researched along with Mental Disorders in 266 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Zelen II design method was used; 124 patients with acute mental disorders due to amphetamine were randomly divided into olanzapine group (n = 63) and haloperidol group (n = 61)." | 9.27 | Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants: A randomized controlled trial. ( Chen, X; Fan, Q; Song, Y; Tang, J; Xue, X; Yu, X, 2018) |
| "To evaluate weight gain associated with olanzapine, risperidone, and haloperidol treatment and its clinical risk factors in adolescent patients." | 7.71 | Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. ( Apter, A; Brand-Gothelf, A; Gal, G; Gothelf, D; Kikinzon, L; Phillip, M; Ratzoni, G; Reidman, J; Weizman, R, 2002) |
| "Weight gain induced by clozapine or olanzapine appears to be associated with an increase in leptin level that cannot be attributed to dietary changes upon hospitalization." | 7.70 | Body weight and leptin plasma levels during treatment with antipsychotic drugs. ( Haack, M; Hinze-Selch, D; Kraus, T; Kühn, M; Pollmächer, T; Schuld, A; Uhr, M, 1999) |
| "Cocaine-related rhabdomyolysis has a high mortality." | 5.29 | Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome? ( Daras, M; Kakkouras, L; Koppel, BS; Tuchman, AJ, 1995) |
| "The Zelen II design method was used; 124 patients with acute mental disorders due to amphetamine were randomly divided into olanzapine group (n = 63) and haloperidol group (n = 61)." | 5.27 | Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants: A randomized controlled trial. ( Chen, X; Fan, Q; Song, Y; Tang, J; Xue, X; Yu, X, 2018) |
| " Aggression decreased substantially with all three treatments by 4 weeks, with the placebo group showing the greatest change (median decrease in MOAS score after 4 weeks=9 [95% CI 5-14] for placebo, 79% from baseline; 7 [4-14] for risperidone, 58% from baseline; 6." | 5.13 | Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial. ( Ahmed, Z; Bhaumik, S; Bouras, N; Cooray, S; Crawford, M; Deb, S; Eliahoo, J; Hare, M; Harley, D; Karatela, S; Kramo, K; Meade, M; Murphy, D; North, B; Oliver-Africano, PC; Rao, B; Reece, B; Regan, A; Soni, A; Thomas, D; Tyrer, P, 2008) |
| " Midazolam was more rapidly sedating than haloperidol-promethazine, reducing the time people are exposed to aggression." | 5.10 | Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine. ( , 2003) |
| "To report a case of fatal hyponatremia, marked hyperglycemia, and acute pancreatitis following simultaneous administration of paroxetine, fluphenazine, haloperidol and olanzapine." | 3.74 | Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy. ( Alfirevic, Z; Degoricija, V; Vucicevic, Z; Vukicevic-Badouin, D, 2007) |
| "To evaluate weight gain associated with olanzapine, risperidone, and haloperidol treatment and its clinical risk factors in adolescent patients." | 3.71 | Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. ( Apter, A; Brand-Gothelf, A; Gal, G; Gothelf, D; Kikinzon, L; Phillip, M; Ratzoni, G; Reidman, J; Weizman, R, 2002) |
| "Weight gain induced by clozapine or olanzapine appears to be associated with an increase in leptin level that cannot be attributed to dietary changes upon hospitalization." | 3.70 | Body weight and leptin plasma levels during treatment with antipsychotic drugs. ( Haack, M; Hinze-Selch, D; Kraus, T; Kühn, M; Pollmächer, T; Schuld, A; Uhr, M, 1999) |
| "Neuroleptic malignant syndrome was diagnosed in a 27-year-old pregnant female with a psychiatric disorder, after treatment with haloperidol." | 3.69 | [Successful electroconvulsive therapy in a pregnant woman with neuroleptic malignant syndrome]. ( Bosch, FH; Heinis, C; Thies, JE; Verwey, B; Verwiel, JM, 1994) |
| " No alpha-MSH could be detected in plasma of normal subjects (n = 6), in plasma of patients with Addison's disease (n = 3), Nelson's syndrome (n = 2), bromocriptine responsive (n = 2) and unresponsive (n = 5) Cushing's disease and in plasma of psychiatric patients on chronic treatment with the dopamine antagonist haloperidol (n = 5)." | 3.68 | Absence of detectable immunoreactive alpha melanocyte stimulating hormone in plasma in various types of Cushing's disease. ( Croughs, RJ; Mol, JA; Thijssen, JH, 1991) |
| " Overall, 25 years of experience have indicated that haloperidol can be used safely and effectively to manage a variety of psychiatric illnesses, so long as dosage and method of administration are adjusted to individual patients' needs." | 2.65 | Haloperidol: a quarter century of experience. ( Ayd, FJ; Settle, EC, 1983) |
| "Sydenham's chorea is best considered a neuropsychiatric disorder, and most patients will benefit from psychiatric treatment." | 2.39 | Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review. ( Moore, DP, 1996) |
| "Early identification and treatment of panic disorder might help to avoid unnecessary repeated emergency department visits, and at the same time reduce the associated high risk of suicide and other psychiatric disorders such as depression as well as drug and alcohol abuse." | 2.38 | [Emergency: the internist as psychiatrist]. ( Knüsel, H, 1993) |
| " It is suggested that additional studies, carefully designed, on dosage and plasma levels could help in achieving the lowest possible therapeutic dosage and thus in minimizing side effects." | 2.37 | Blood levels of neuroleptics: state of the art. ( Simpson, GM; Yadalam, K, 1985) |
| " It appears that although haloperidol disposition can be described by linear kinetics in volunteers, this is not the case in patients in whom a 7--10-fold variability in plasma levels is observed for the same dosage together with the possibility of saturation kinetics and/or first pass effect." | 2.36 | Haloperidol plasma level monitoring in neuropsychiatric patients. ( Bianchetti, G; Dugas, M; Morselli, PL, 1982) |
| "In previous animal studies of psychiatric disorders associated with 22q11." | 1.62 | Two novel mouse models mimicking minor deletions in 22q11.2 deletion syndrome revealed the contribution of each deleted region to psychiatric disorders. ( Aiba, A; Funato, H; Koebis, M; Kushima, I; Miyoshi, C; Mori, D; Nakao, K; Ozaki, N; Saito, R; Yanagisawa, M, 2021) |
| "UHDRS (Unified Huntington's Disease Rating Scale) motor scores were obtained from medical records as an index of disease progression." | 1.42 | Examining Huntington's disease patient and informant concordance on frontally mediated behaviors. ( Cimino, CR; Hergert, DC; Sanchez-Ramos, J, 2015) |
| " This multifunctional drug candidate is orally bioavailable and exhibits good antipsychotic efficacy in vivo." | 1.40 | Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders. ( Beard, JD; Davis, RE; Hendrick, JP; Lee, T; Li, P; Mates, S; Peng, Y; Robichaud, AJ; Snyder, GL; Tomesch, J; Vanover, KE; Wennogle, LP; Yao, W; Zhang, Q; Zhu, H, 2014) |
| "Co-morbid substance abuse was uncommon." | 1.39 | Prevalence and clinical presentation of HIV positive female psychiatric inpatients. ( Uys, H, 2013) |
| "Haloperidol plasma levels were measured at the same timepoints." | 1.37 | Lack of association between 71 variations located in candidate genes and response to acute haloperidol treatment. ( De Ronchi, D; Drago, A; Giegling, I; Hartmann, AM; Möller, HJ; Rujescu, D; Sander, T; Schäfer, M; Serretti, A; Stassen, HH; Toliat, MR, 2011) |
| "The definition of the best combination of "when" and "how much" of haloperidol dosing during acute psychotic illness still represents a challenge." | 1.36 | Interaction of haloperidol plasma level and antipsychotic effect in early phases of acute psychosis treatment. ( Drago, A; Giegling, I; Möller, HJ; Rujescu, D; Schäfer, M; Serretti, A, 2010) |
| "Treatment with risperidone solution orally or parenteral haloperidol until the day after admission, followed by olanzapine, successfully improved the clinical condition of the patients." | 1.35 | Three cases of schizophrenia for which olanzapine was effective after early acute phase. ( Inada, T; Oda, T; Yamamoto, N, 2008) |
| "Haloperidol has been included in the World Health Organisation's list of essential medicines." | 1.35 | The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. ( Alamo, C; López-Muñoz, F, 2009) |
| "Haloperidol has been found to be very efficient in controlling agitation with or without pain, nausea and/or vomiting of central origin, intestinal obstruction, and delirium." | 1.33 | Stability of tramadol and haloperidol for continuous subcutaneous infusion at home. ( Azuara, ML; Barcia, E; Martín, A; Negro, S; Sánchez, Y, 2005) |
| "Debrisoquine MR was correlated with the dose of haloperidol (r = 0." | 1.32 | Relationship between haloperidol plasma concentration, debrisoquine metabolic ratio, CYP2D6 and CYP2C9 genotypes in psychiatric patients. ( Berecz, R; de la Rubia, A; Dorado, P; LLerena, A, 2004) |
| " At a lower daily dosage of HAL (<10 mg/day), the subjects with two or one CYP2D6*10 allele(s) showed significantly higher plasma concentrations of RHAL (0." | 1.32 | Effect of CYP2D6 genotypes on the metabolism of haloperidol in a Japanese psychiatric population. ( Hirokane, G; Kawashima, Y; Morita, S; Sato, S; Shimoda, K; Someya, T; Suzuki, Y; Takahashi, S; Yokono, A, 2003) |
| "The authors studied the effect of aging and the CYP2D6*10 polymorphism on the plasma haloperidol (HAL) concentration after chronic administration of HAL." | 1.32 | Effects of age and the CYP2D6*10 allele on the plasma haloperidol concentration/dose ratio. ( Ikemoto, K; Ishibashi, K; Ohara, K; Shibuya, H; Tanabu, S; Yoshida, K, 2003) |
| "Retrospective population pharmacokinetic study." | 1.31 | Population pharmacokinetics of haloperidol using routine clinical pharmacokinetic data in Japanese patients. ( Anai, M; Goto, Y; Higuchi, S; Hokazono, T; Ichimaru, R; Maki, T; Matsunaga, K; Ohdo, S; Yukawa, E; Yukawa, M, 2002) |
| "Unlike the more common causes of dysphagia, especially in the elderly, drug-induced dysphagia may be reversible." | 1.30 | Neuroleptic-induced dysphagia. ( Pavlakovic, R; Sokoloff, LG, 1997) |
| "Cocaine-related rhabdomyolysis has a high mortality." | 1.29 | Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome? ( Daras, M; Kakkouras, L; Koppel, BS; Tuchman, AJ, 1995) |
| "The haloperidol dosage was held at 9:00 a." | 1.28 | Haloperidol and reduced haloperidol in saliva and blood. ( Dysken, MW; Holden, L; Johnson, SB; Kuskowski, M; Ofstehage, J; Skare, S; Vatassery, G, 1992) |
| "Haloperidol was implicated in 47 patients (37%), followed by amitriptyline/perphenazine in 30%, thioridazine in 27%, and chlorpromazine in 20%." | 1.28 | Neurologic approach to drug-induced movement disorders: a study of 125 patients. ( Jankovic, J; Miller, LG, 1990) |
| "Haloperidol serum levels were determined by the recently developed radioimmunoassay technique to elucidate the relationship between serum levels and clinical effects and that between serum levels and adverse effects." | 1.27 | Monitoring of haloperidol serum levels and it's clinical significance. ( Fujii, Y; Ichikawa, K; Itoh, H; Iwamura, K; Tateyama, M; Yagi, G, 1984) |
| "Tourette's syndrome is a widely misunderstood chronic disorder that develops in childhood and is usually lifelong." | 1.27 | Tourette's syndrome: update. ( Baird, PA; Connolly, JE; Freeman, RD, 1984) |
| "The authors studied high-potency versus low-potency neuroleptic dosing practices for 110 Boston-area psychiatric inpatients and compared the findings with the dosing practices reported in surveys of nearly 16,000 Veterans Administration patients." | 1.27 | Dissimilar dosing with high-potency and low-potency neuroleptics. ( Baldessarini, RJ; Cotton, P; Katz, B, 1984) |
| " Such variations have been attributed to individual metabolism, pharmacologic differences, and age--all of which may need careful consideration in prescribing an appropriate dosage regimen for a given patient." | 1.27 | Interpatient variations in antipsychotic therapy. ( Gershon, S; McIntyre, IM, 1985) |
| " This led to the hope that measuring neuroleptic concentrations would allow more effective oral dosing for individual psychotic patients." | 1.27 | Neuroleptic blood levels and clinical response. ( Rockland, LH, 1986) |
| "It is the drug of choice for Tourette's syndrome, and may be useful in nonpsychotic hyperactive or aggressive children to control acute episodes, or when the stimulants normally useful in hyperactive children are ineffective." | 1.26 | Haloperidol -- its use in children. ( Serrano, AC, 1981) |
| " Data in adult patients illustrate on the one hand possible causes of variability in plasma levels of haloperidol and, on the other hand, the fact that poor bioavailability is not the cause of lack of response in 'resistant' schizophrenic patients." | 1.26 | Clinical significance of monitoring plasma levels of psychotropic drugs. ( Morselli, PL; Zarifian, E, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 171 (64.29) | 18.7374 |
| 1990's | 34 (12.78) | 18.2507 |
| 2000's | 38 (14.29) | 29.6817 |
| 2010's | 21 (7.89) | 24.3611 |
| 2020's | 2 (0.75) | 2.80 |
| Authors | Studies |
|---|---|
| Li, P | 1 |
| Zhang, Q | 1 |
| Robichaud, AJ | 1 |
| Lee, T | 1 |
| Tomesch, J | 1 |
| Yao, W | 1 |
| Beard, JD | 1 |
| Snyder, GL | 1 |
| Zhu, H | 1 |
| Peng, Y | 1 |
| Hendrick, JP | 1 |
| Vanover, KE | 1 |
| Davis, RE | 1 |
| Mates, S | 1 |
| Wennogle, LP | 1 |
| Saito, R | 1 |
| Miyoshi, C | 1 |
| Koebis, M | 1 |
| Kushima, I | 1 |
| Nakao, K | 1 |
| Mori, D | 1 |
| Ozaki, N | 1 |
| Funato, H | 1 |
| Yanagisawa, M | 1 |
| Aiba, A | 1 |
| Lin, M | 1 |
| Rasmussen, SA | 1 |
| Rosebush, PI | 1 |
| Mazurek, MF | 1 |
| Xue, X | 1 |
| Song, Y | 1 |
| Yu, X | 1 |
| Fan, Q | 1 |
| Tang, J | 1 |
| Chen, X | 1 |
| Uys, H | 1 |
| Aberg, KA | 1 |
| Xie, LY | 1 |
| McClay, JL | 1 |
| Nerella, S | 1 |
| Vunck, S | 1 |
| Snider, S | 1 |
| Beardsley, PM | 1 |
| van den Oord, EJ | 1 |
| Calver, L | 1 |
| Drinkwater, V | 1 |
| Isbister, GK | 1 |
| Citraro, R | 1 |
| Leo, A | 1 |
| Aiello, R | 1 |
| Pugliese, M | 1 |
| Russo, E | 1 |
| De Sarro, G | 1 |
| Hergert, DC | 1 |
| Sanchez-Ramos, J | 1 |
| Cimino, CR | 1 |
| Barbui, C | 1 |
| Bighelli, I | 1 |
| Carrà, G | 1 |
| Castellazzi, M | 1 |
| Lucii, C | 1 |
| Martinotti, G | 1 |
| Nosè, M | 1 |
| Ostuzzi, G | 1 |
| Šimić, I | 1 |
| Potočnjak, I | 1 |
| Kraljičković, I | 1 |
| Stanić Benić, M | 1 |
| Čegec, I | 1 |
| Juričić Nahal, D | 1 |
| Ganoci, L | 1 |
| Božina, N | 1 |
| Korade, Ž | 1 |
| Liu, W | 1 |
| Warren, EB | 1 |
| Armstrong, K | 1 |
| Porter, NA | 1 |
| Konradi, C | 1 |
| Dankert, ME | 1 |
| Brensinger, CM | 1 |
| Metzger, KL | 1 |
| Li, C | 1 |
| Koleva, SG | 1 |
| Mesén, A | 1 |
| Laprade, B | 1 |
| Wiguna, T | 1 |
| Han, C | 1 |
| Farooq, S | 1 |
| Severus, WE | 1 |
| Gayares, JG | 1 |
| Langosch, JM | 1 |
| Lallart, X | 1 |
| Tateno, M | 1 |
| Mihai, A | 1 |
| Nair, SR | 1 |
| Belmaker, R | 1 |
| Rybakowski, J | 1 |
| Owe-Larsson, B | 1 |
| Kane, JM | 1 |
| Johnstone, EC | 1 |
| MacIntyre, DJ | 1 |
| Malhotra, S | 1 |
| González-Pinto, A | 1 |
| Mosquera, F | 1 |
| Babb, SM | 1 |
| Habib pour, E | 1 |
| Fatemi, SS | 1 |
| Swanson, C | 1 |
| Adler, C | 1 |
| Young, A | 1 |
| Hoeft, F | 1 |
| Sivakumar, K | 1 |
| Radoeva, PD | 1 |
| Lallart, EA | 1 |
| Bilker, WB | 1 |
| Siegel, SJ | 1 |
| Crespo-Facorro, B | 1 |
| Roiz-Santiáñez, R | 1 |
| Pérez-Iglesias, R | 1 |
| Pelayo-Terán, JM | 1 |
| Rodríguez-Sánchez, JM | 1 |
| Tordesillas-Gutiérrez, D | 1 |
| Ramírez, M | 1 |
| Martínez, O | 1 |
| Gutiérrez, A | 1 |
| de Lucas, EM | 1 |
| Vázquez-Barquero, JL | 1 |
| López-Muñoz, F | 1 |
| Alamo, C | 1 |
| Cardoso, L | 1 |
| Galera, SA | 1 |
| Romeo, R | 1 |
| Knapp, M | 1 |
| Tyrer, P | 2 |
| Crawford, M | 2 |
| Oliver-Africano, P | 1 |
| Andreasen, NC | 1 |
| Pressler, M | 1 |
| Nopoulos, P | 1 |
| Miller, D | 1 |
| Ho, BC | 1 |
| Giegling, I | 2 |
| Drago, A | 2 |
| Schäfer, M | 2 |
| Möller, HJ | 2 |
| Rujescu, D | 2 |
| Serretti, A | 2 |
| Hatta, K | 1 |
| Nakamura, M | 1 |
| Yoshida, K | 3 |
| Hamakawa, H | 1 |
| Wakejima, T | 1 |
| Nishimura, T | 1 |
| Furuta, K | 1 |
| Kawabata, T | 1 |
| Hirata, T | 1 |
| Usui, C | 1 |
| Nakamura, H | 1 |
| Sawa, Y | 1 |
| Brakoulias, V | 1 |
| Mandali, R | 1 |
| Seymour, J | 1 |
| Sammut, P | 1 |
| Starcevic, V | 1 |
| Cohen, D | 1 |
| de Hert, M | 1 |
| Preskorn, SH | 1 |
| Hartmann, AM | 1 |
| Sander, T | 1 |
| Toliat, MR | 1 |
| De Ronchi, D | 1 |
| Stassen, HH | 1 |
| Stauffer, VL | 1 |
| Case, M | 1 |
| Kinon, BJ | 1 |
| Conley, R | 1 |
| Ascher-Svanum, H | 1 |
| Kollack-Walker, S | 1 |
| Kane, J | 1 |
| McEvoy, J | 1 |
| Lieberman, J | 1 |
| Green, L | 1 |
| Matos, P | 1 |
| Murillo, I | 1 |
| Neushotz, L | 1 |
| Popeo, D | 1 |
| Aloysi, A | 1 |
| Samuel, J | 1 |
| Craig, E | 1 |
| Porter, C | 1 |
| Fitzpatrick, JJ | 1 |
| Georgieva, I | 1 |
| Mulder, CL | 1 |
| Noorthoorn, E | 1 |
| Smith, C | 1 |
| Felce, D | 1 |
| Ahmed, Z | 2 |
| Fraser, WI | 1 |
| Kerr, M | 1 |
| Kiernan, C | 1 |
| Emerson, E | 1 |
| Robertson, J | 1 |
| Allen, D | 1 |
| Baxter, H | 1 |
| Thomas, J | 1 |
| Huf, G | 3 |
| Coutinho, ES | 2 |
| Adams, CE | 4 |
| Onalaja, D | 1 |
| Jainer, AK | 1 |
| Ohara, K | 2 |
| Tanabu, S | 2 |
| Ishibashi, K | 2 |
| Ikemoto, K | 2 |
| Shibuya, H | 2 |
| Someya, T | 4 |
| Shimoda, K | 1 |
| Suzuki, Y | 1 |
| Sato, S | 1 |
| Kawashima, Y | 1 |
| Hirokane, G | 1 |
| Morita, S | 1 |
| Yokono, A | 1 |
| Takahashi, S | 4 |
| Faustino, PC | 1 |
| Terreri, MT | 1 |
| da Rocha, AJ | 1 |
| Zappitelli, MC | 1 |
| Lederman, HM | 1 |
| Hilário, MO | 1 |
| Ohnuma, T | 1 |
| Shibata, N | 1 |
| Matsubara, Y | 1 |
| Arai, H | 1 |
| DIVRY, P | 2 |
| BOBON, J | 2 |
| COLLARD, J | 3 |
| PINCHARD, A | 1 |
| NOLS, E | 1 |
| AZIMA, H | 1 |
| DUROST, H | 1 |
| ARTHURS, D | 1 |
| CARON, M | 1 |
| DUSSARTRE, J | 1 |
| GERANDAL, C | 1 |
| EVRARD, E | 1 |
| MOLDERS, V | 1 |
| FLEGEL, H | 1 |
| GERLE, B | 4 |
| PETERSSON, B | 1 |
| WIDMARK, M | 1 |
| GIACOBINI, E | 1 |
| LASSENIUS, B | 1 |
| GUILBERT, P | 1 |
| FERON, A | 1 |
| MONCEAUX, JP | 1 |
| HARENKO, A | 1 |
| KIJANEN, I | 1 |
| PIHKANEN, T | 1 |
| DI CRISTO, G | 1 |
| OLES, M | 2 |
| SCHWARZ, H | 2 |
| JUENEMANN, HJ | 2 |
| KRUEGER, HJ | 2 |
| LINDQVIST, R | 1 |
| ALLEVA, PM | 1 |
| CHANTRAINE, J | 1 |
| MEURICE, E | 1 |
| PAIROUX, R | 1 |
| DE HAENE, A | 1 |
| DELAY, J | 3 |
| PICHOT, P | 3 |
| LEMPERIERE, T | 3 |
| ELISSALDE, B | 3 |
| PEIGNE, F | 1 |
| ALDEGHI, E | 1 |
| MADERNA, A | 1 |
| BISTER, W | 1 |
| ENTWISTLE, C | 1 |
| TAYLOR, RM | 1 |
| MACDONALD, IA | 1 |
| GASTAUT, H | 1 |
| DONGIER, S | 1 |
| DONGIER, M | 1 |
| FAIDHEREBE, J | 1 |
| OOSTERBAAN, WM | 1 |
| PALAIOLOGOS, A | 1 |
| SIGALOS, I | 1 |
| SPATHARAS, G | 1 |
| TERENTIOS, E | 1 |
| GAVAUDAN, L | 1 |
| SALVAING, J | 1 |
| SPORTOUCH, Y | 1 |
| SZOBOR, A | 2 |
| STEENFELDT-FOSS, OW | 1 |
| RAVINA, A | 1 |
| VELLOSO, FM | 1 |
| PAPROCKI, J | 1 |
| DENBER, HC | 1 |
| SVENDSEN, BB | 1 |
| WILLADSEN, J | 1 |
| GALINDEZ, L | 1 |
| SANTOS, MR | 1 |
| BOREL, RO | 1 |
| FOURNY, L | 1 |
| COMBETTE, H | 1 |
| STEPHANOPOLI, J | 1 |
| VALLADE, L | 1 |
| CORSETTI, R | 1 |
| ACUSSERUIZ, DG | 1 |
| MALUF, L | 1 |
| OKASHA, A | 1 |
| TEWFIK, GI | 1 |
| LEONE, BN | 1 |
| BOHACEK, N | 1 |
| MARQUEZ, C | 1 |
| GAGO, MI | 1 |
| LUCIANO, M | 1 |
| LAGOCKI, AM | 1 |
| PASQUALINI, G | 1 |
| QUINCI, A | 1 |
| SARADJIEFF, P | 1 |
| SHYSTER, M | 1 |
| BUIS, C | 1 |
| FLOHIL, JM | 1 |
| ROTH, M | 1 |
| HAWARD, LR | 1 |
| SABBATINI, F | 1 |
| SUGERMAN, AA | 1 |
| WILLIAMS, BH | 1 |
| ADLERSTEIN, AM | 1 |
| SCHNEIDER, J | 1 |
| THOMALSKE, G | 1 |
| PERRIN, J | 1 |
| SIFFERMANN, A | 1 |
| NAYRAC, P | 2 |
| ARNOTT, G | 2 |
| MILBLED, G | 2 |
| VOLMAT, R | 1 |
| BEAUDOUIN, JL | 1 |
| COLLIN, J | 1 |
| NICOLAS-CHARLES, PJ | 1 |
| ALLERS, G | 1 |
| LURIA, E | 1 |
| RIZZUTO, N | 1 |
| LUNA, NE | 1 |
| Faurbye, A | 1 |
| Clausen, J | 1 |
| CHAPEL, JL | 1 |
| BROWN, N | 1 |
| JENKINS, RL | 1 |
| BROUSSOLLE, P | 1 |
| GRUNTHALER, C | 1 |
| CARDO, WN | 1 |
| DE FORTES, JR | 1 |
| DE CARVALHO, HM | 1 |
| GONCALVES, J | 1 |
| HUMBEECK, L | 1 |
| JACOBS, R | 1 |
| KRISTJANSEN, P | 1 |
| LORET, L | 1 |
| PAQUAY, J | 2 |
| ARNOULD, F | 2 |
| BURTON, P | 2 |
| SCARLATO, G | 1 |
| ROVETTA, P | 1 |
| JENSEN, OO | 1 |
| Ushizima, M | 2 |
| Amano, N | 1 |
| Mosolov, SN | 1 |
| Kabanov, SO | 1 |
| Roubert, C | 1 |
| Spielewoy, C | 1 |
| Soubrié, P | 1 |
| Hamon, M | 1 |
| Giros, B | 1 |
| Betancur, C | 1 |
| LLerena, A | 1 |
| de la Rubia, A | 1 |
| Berecz, R | 1 |
| Dorado, P | 1 |
| Espinosa-Avilés, D | 1 |
| Elizondo, G | 1 |
| Morales-Martínez, M | 1 |
| Rodríguez-Herrejón, F | 1 |
| Varela, P | 1 |
| Alexander, J | 2 |
| Tharyan, P | 2 |
| Adams, C | 1 |
| John, T | 1 |
| Mol, C | 1 |
| Philip, J | 1 |
| Guimarães, CA | 1 |
| Franzon, RC | 1 |
| Souza, EA | 1 |
| Schmutzler, KM | 1 |
| Montenegro, MA | 1 |
| Queiroz, Lde S | 1 |
| Cendes, F | 1 |
| Guerreiro, MM | 1 |
| Lima, MS | 1 |
| Soares, BG | 1 |
| Bobes, J | 1 |
| Cañas, F | 1 |
| Rejas, J | 1 |
| Mackell, J | 1 |
| Narumoto, J | 1 |
| Matsushima, N | 1 |
| Oka, S | 1 |
| Shimizu, H | 1 |
| Kooguchi, Y | 1 |
| Kitabayashi, Y | 1 |
| Kunizawa, M | 1 |
| Ueda, H | 1 |
| Fukui, K | 1 |
| Justo, D | 1 |
| Prokhorov, V | 1 |
| Heller, K | 1 |
| Zeltser, D | 1 |
| Jhirwal, OP | 1 |
| Kulhara, P | 1 |
| Basu, D | 1 |
| Negro, S | 1 |
| Martín, A | 1 |
| Azuara, ML | 1 |
| Sánchez, Y | 1 |
| Barcia, E | 1 |
| Suh, GH | 2 |
| Shah, A | 1 |
| Watari, M | 1 |
| Greenspan, AJ | 1 |
| Choi, SK | 1 |
| Vucicevic, Z | 1 |
| Degoricija, V | 1 |
| Alfirevic, Z | 1 |
| Vukicevic-Badouin, D | 1 |
| Raveendran, NS | 1 |
| Oliver-Africano, PC | 1 |
| Bouras, N | 1 |
| Cooray, S | 1 |
| Deb, S | 1 |
| Murphy, D | 1 |
| Hare, M | 1 |
| Meade, M | 1 |
| Reece, B | 1 |
| Kramo, K | 1 |
| Bhaumik, S | 1 |
| Harley, D | 1 |
| Regan, A | 1 |
| Thomas, D | 1 |
| Rao, B | 1 |
| North, B | 1 |
| Eliahoo, J | 1 |
| Karatela, S | 1 |
| Soni, A | 1 |
| Yamamoto, N | 1 |
| Oda, T | 1 |
| Inada, T | 1 |
| Huot, J | 1 |
| Bordeleau, JM | 2 |
| Tetreault, L | 2 |
| Thomas, C | 1 |
| Tatham, A | 1 |
| Jakubowski, S | 1 |
| Schiele, B | 1 |
| Baldessarini, RJ | 1 |
| Katz, B | 1 |
| Cotton, P | 1 |
| Morselli, PL | 5 |
| Bianchetti, G | 3 |
| Dugas, M | 2 |
| Gualtieri, CT | 1 |
| Golden, R | 1 |
| Evans, RW | 1 |
| Hicks, RE | 1 |
| Meltzer, HY | 1 |
| Barbosa, ER | 1 |
| Marchiori, PE | 1 |
| Scaff, M | 1 |
| de Assis, JL | 1 |
| Settle, EC | 1 |
| Ayd, FJ | 4 |
| Schmidt, LG | 1 |
| Grohmann, R | 1 |
| Helmchen, H | 2 |
| Langscheid-Schmidt, K | 1 |
| Müller-Oerlinghausen, B | 1 |
| Poser, W | 1 |
| Rüther, E | 1 |
| Scherer, J | 1 |
| Strauss, A | 1 |
| Wolf, B | 1 |
| Itoh, H | 1 |
| Yagi, G | 1 |
| Tateyama, M | 1 |
| Fujii, Y | 1 |
| Iwamura, K | 1 |
| Ichikawa, K | 1 |
| Freeman, RD | 1 |
| Connolly, JE | 1 |
| Baird, PA | 1 |
| Serrano, AC | 1 |
| Moleman, P | 1 |
| Schmitz, PJ | 1 |
| Ladee, GA | 1 |
| Shopsin, B | 2 |
| Kline, N | 1 |
| Risberg, J | 1 |
| Zarifian, E | 2 |
| Cuche, H | 1 |
| Cotterau, MJ | 1 |
| Deniker, P | 1 |
| Daras, M | 1 |
| Kakkouras, L | 1 |
| Tuchman, AJ | 1 |
| Koppel, BS | 1 |
| Xiang, M | 1 |
| Ran, M | 1 |
| Li, S | 1 |
| Lal, S | 1 |
| Bloom, D | 1 |
| Silver, B | 1 |
| Desjardins, B | 1 |
| Krishnan, B | 1 |
| Thavundayil, J | 1 |
| Thompson, T | 1 |
| Verwiel, JM | 1 |
| Verwey, B | 1 |
| Heinis, C | 1 |
| Thies, JE | 1 |
| Bosch, FH | 1 |
| Bartlett, EJ | 1 |
| Brodie, JD | 1 |
| Simkowitz, P | 1 |
| Dewey, SL | 1 |
| Rusinek, H | 1 |
| Wolf, AP | 1 |
| Fowler, JS | 1 |
| Volkow, ND | 1 |
| Smith, G | 1 |
| Wolkin, A | 1 |
| Silva, JA | 1 |
| Leong, GB | 1 |
| Weinstock, R | 1 |
| Prasher, VP | 1 |
| Barrett, K | 1 |
| Knüsel, H | 1 |
| Reding, KM | 1 |
| Reding, GR | 1 |
| Nielssen, O | 1 |
| Buhrich, N | 1 |
| Finlay-Jones, R | 1 |
| Tamminga, CA | 1 |
| Conley, RR | 1 |
| Sokoloff, LG | 1 |
| Pavlakovic, R | 1 |
| Stein, DJ | 1 |
| Laszlo, B | 1 |
| Marais, E | 1 |
| Seedat, S | 1 |
| Potocnik, F | 1 |
| Pan, L | 1 |
| Rosseel, MT | 1 |
| Belpaire, FM | 1 |
| Strauss, AJ | 1 |
| Bailey, RK | 1 |
| Dralle, PW | 1 |
| Eschmann, AJ | 1 |
| Wagner, RB | 1 |
| Moore, DP | 1 |
| Kraus, T | 1 |
| Haack, M | 1 |
| Schuld, A | 1 |
| Hinze-Selch, D | 1 |
| Kühn, M | 1 |
| Uhr, M | 1 |
| Pollmächer, T | 1 |
| Furrows, DC | 1 |
| Jeste, DV | 1 |
| Lacro, JP | 1 |
| Bailey, A | 1 |
| Rockwell, E | 1 |
| Harris, MJ | 1 |
| Caligiuri, MP | 1 |
| Chambers, RA | 1 |
| Druss, BG | 1 |
| Binder, RL | 1 |
| McNiel, DE | 1 |
| Coley, KC | 1 |
| Carter, CS | 1 |
| DaPos, SV | 1 |
| Maxwell, R | 1 |
| Wilson, JW | 1 |
| Branch, RA | 1 |
| Rymsha, SV | 1 |
| Zhuchenko, LN | 1 |
| Zhuchenko, IA | 1 |
| da Silva Freire Coutinho, E | 1 |
| Fagundes, HM | 1 |
| Oliveira, ES | 1 |
| Lopez, JR | 1 |
| Gewandszajder, M | 1 |
| da Luz Carvalho, A | 1 |
| Keusen, A | 1 |
| Ratzoni, G | 1 |
| Gothelf, D | 1 |
| Brand-Gothelf, A | 1 |
| Reidman, J | 1 |
| Kikinzon, L | 1 |
| Gal, G | 1 |
| Phillip, M | 1 |
| Apter, A | 1 |
| Weizman, R | 1 |
| Yukawa, E | 1 |
| Hokazono, T | 1 |
| Yukawa, M | 1 |
| Ichimaru, R | 1 |
| Maki, T | 1 |
| Matsunaga, K | 1 |
| Ohdo, S | 1 |
| Anai, M | 1 |
| Higuchi, S | 1 |
| Goto, Y | 1 |
| Val'dman, AV | 1 |
| Kozlovskaia, MM | 1 |
| Dencker, SJ | 1 |
| Scharbach, H | 1 |
| Steiner, M | 1 |
| Elizur, A | 1 |
| Davidson, S | 1 |
| Nadel, I | 1 |
| Wallach, M | 1 |
| Guirguis, EF | 1 |
| Tignol, J | 1 |
| Bourgeois, M | 2 |
| Shapiro, AK | 2 |
| Castrogiovanni, P | 1 |
| Cassano, GB | 1 |
| Conti, L | 1 |
| Maggini, C | 1 |
| Bonollo, L | 1 |
| Sarteschi, P | 1 |
| Howard, JS | 1 |
| Markianos, ES | 1 |
| Nyström, I | 1 |
| Reichel, H | 1 |
| Matussek, N | 1 |
| Evans, L | 2 |
| Van Praag, HM | 1 |
| Korf, J | 1 |
| Oldham, AJ | 2 |
| Baastrup, PC | 1 |
| Hollnagel, P | 1 |
| Sorensen, R | 1 |
| Schou, M | 1 |
| Iveson-Iveson, J | 1 |
| Swett, C | 1 |
| Hussey, HH | 1 |
| Ruskin, R | 1 |
| Ananth, J | 1 |
| Bernad, P | 1 |
| Burgio, LD | 1 |
| Sinnott, J | 1 |
| Janosky, JE | 1 |
| Hohman, MJ | 1 |
| Cohen, DJ | 1 |
| Riddle, MA | 1 |
| Leckman, JF | 1 |
| Shibasaki, M | 3 |
| Noguchi, T | 1 |
| Inaba, T | 2 |
| Dysken, MW | 1 |
| Johnson, SB | 1 |
| Holden, L | 1 |
| Kuskowski, M | 1 |
| Ofstehage, J | 1 |
| Skare, S | 1 |
| Vatassery, G | 1 |
| Croughs, RJ | 1 |
| Thijssen, JH | 1 |
| Mol, JA | 1 |
| Stárková, L | 1 |
| Wiedermann, J | 1 |
| Cournoyer, J | 1 |
| Monette, Y | 1 |
| Miller, LG | 1 |
| Jankovic, J | 1 |
| MacDonell, JE | 1 |
| Wrenn, K | 1 |
| Cheung, SW | 1 |
| Tang, SW | 1 |
| Kato, T | 1 |
| Arai, M | 1 |
| Lienert, GA | 1 |
| Bergman, LR | 1 |
| Fuglum, E | 1 |
| Schillinger, A | 1 |
| Andersen, JB | 1 |
| Belstad, BE | 1 |
| Jensen, D | 1 |
| Müller, F | 1 |
| Müller, KJ | 1 |
| Schulstad, B | 1 |
| Elgen, K | 1 |
| Lande, RG | 1 |
| Wise, TN | 1 |
| Mann, LS | 1 |
| Jani, N | 1 |
| Kass, EB | 1 |
| Goldwater, S | 1 |
| Sonnenschein, K | 1 |
| Goldney, R | 1 |
| Bowes, J | 1 |
| Spence, N | 1 |
| Czechowicz, A | 1 |
| Hurley, R | 1 |
| Simpson, GM | 1 |
| Yadalam, K | 1 |
| McIntyre, IM | 1 |
| Gershon, S | 2 |
| Rockland, LH | 1 |
| Addonizio, G | 1 |
| Alexopoulos, GS | 1 |
| Birnie, WA | 1 |
| Matsuno, K | 1 |
| Walton, R | 1 |
| Menza, MA | 1 |
| Murray, GB | 1 |
| Holmes, VF | 1 |
| Rafuls, WA | 1 |
| Browne, JL | 1 |
| Hart, RR | 1 |
| Claghorn, JL | 1 |
| de Groot, MH | 1 |
| Davis, JM | 2 |
| Ott, J | 1 |
| Müller, E | 1 |
| Heidrich, R | 1 |
| Chiu, E | 1 |
| Kammerer, T | 1 |
| Singer, L | 1 |
| Kempf, MT | 1 |
| Klotz, JP | 1 |
| Jamet, P | 1 |
| Hiltenbrand, JP | 1 |
| Raft, DD | 1 |
| Newmark, C | 1 |
| Toomey, T | 1 |
| Birkett, DP | 1 |
| Boltuch, B | 1 |
| Kazamatsuri, H | 2 |
| Chien, C | 1 |
| Cole, JO | 2 |
| Chien, CP | 1 |
| Lewis, PJ | 1 |
| James, NM | 1 |
| Smith, GR | 1 |
| Taylor, CW | 1 |
| Janowsky, DS | 1 |
| el-Yousef, MK | 1 |
| Fann, WE | 1 |
| Delaunay, J | 1 |
| Guibert, S | 1 |
| Crane, GE | 1 |
| Winslow, WW | 1 |
| Stone, WN | 1 |
| Hofling, CK | 1 |
| Fitzgerald, CH | 1 |
| Olajossy, M | 1 |
| Trojnar, R | 1 |
| Klawans, HL | 1 |
| McKendall, RR | 1 |
| Marcucci, F | 1 |
| Mussini, E | 1 |
| Airoldi, L | 1 |
| Fanelli, R | 1 |
| Frigerio, A | 1 |
| de Nadai, F | 1 |
| Bizzi, A | 1 |
| Rizzo, M | 1 |
| Garattini, S | 1 |
| Baruk, H | 1 |
| Harder, A | 1 |
| Modestin, J | 1 |
| Steiner, H | 1 |
| Bott, M | 1 |
| McCaig, KW | 1 |
| Shapiro, E | 1 |
| Madalena, JC | 1 |
| Ridges, AP | 1 |
| Harper, P | 1 |
| Dally, P | 1 |
| Krasil'nikova, MN | 1 |
| Alisevich, KD | 1 |
| Angyal, L | 2 |
| Tissot, R | 1 |
| Bovet, J | 1 |
| Lapides, MI | 1 |
| Mamtseva, VN | 1 |
| Gottfries, CG | 1 |
| Brophy, JJ | 1 |
| Renard, P | 1 |
| Bicheron, C | 1 |
| Morin, Y | 1 |
| Berthiaume, M | 1 |
| Baser, T | 1 |
| Desrochers, J | 1 |
| Feldman, N | 1 |
| Hamel, O | 1 |
| Hoc, J | 1 |
| Moamai, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Doll Therapy Efficacy for People With Dementia Living in Nursing Homes: a Randomized Single-blind Controlled Trial[NCT03224143] | 128 participants (Anticipated) | Interventional | 2017-02-16 | Enrolling by invitation | |||
| Ketamine Versus Midazolam for Prehospital Agitation[NCT03554915] | 314 participants (Actual) | Observational | 2017-08-01 | Completed | |||
| Rapid Tranquilization of Violent or Agitated People in Psychiatric Emergency Settings- A Pragmatic Randomized Controlled Trial of Intramuscular Olanzepine Vs. Intramuscular Haloperidol + Promethazine.[NCT00455234] | Phase 3 | 300 participants | Interventional | 2005-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for haloperidol and Mental Disorders
| Article | Year |
|---|---|
CNS drug development. Part I: The early period of CNS drugs.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Central | 2010 |
[Brain tumor].
Topics: Antipsychotic Agents; Benzodiazepines; Brain Neoplasms; Haloperidol; Humans; Hydrocephalus; Immunogl | 2003 |
[The appearance of metabolic syndrome in treatment with atypical antipsychotics].
Topics: Adolescent; Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body W | 2003 |
Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors.
Topics: Female; Haloperidol; Humans; Hypokalemia; Male; Mental Disorders; Prevalence; Psychotropic Drugs; Ri | 2005 |
Blood level measurement of psychoactive drugs in pediatric psychiatry.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Central Nervous System Stimulants; Child; Ha | 1984 |
Dopamine autoreceptor stimulation: clinical significance.
Topics: Apomorphine; Dopamine; Haloperidol; Humans; Huntington Disease; Mental Disorders; Neurons; Parkinson | 1982 |
Haloperidol plasma level monitoring in neuropsychiatric patients.
Topics: Chronic Disease; Drug Resistance; Haloperidol; Humans; Kinetics; Mental Disorders; Nervous System Di | 1982 |
[Emergency: the internist as psychiatrist].
Topics: Crisis Intervention; Depressive Disorder; Diagnosis, Differential; Diazepam; Emergencies; Family Pra | 1993 |
The application of neuroimaging techniques to drug development.
Topics: Antipsychotic Agents; Brain; Brain Chemistry; Carbon Radioisotopes; Cerebrovascular Circulation; Deo | 1997 |
Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review.
Topics: Adult; Autoimmune Diseases; Chorea; Comorbidity; Haloperidol; Humans; Mental Disorders; Obsessive-Co | 1996 |
Droperidol: efficacy and side effects in psychiatric emergencies.
Topics: Acute Disease; Animals; Antipsychotic Agents; Clinical Trials as Topic; Crisis Intervention; Dangero | 1999 |
Pharmacotherapy of Tourette's syndrome and associated disorders.
Topics: Attention Deficit Disorder with Hyperactivity; Clonidine; Female; Haloperidol; Humans; Male; Mental | 1992 |
Blood levels of neuroleptics: state of the art.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationship, Drug; Drug | 1985 |
A review of clinical literature on haloperidol.
Topics: Haloperidol; Humans; Mental Disorders | 1967 |
Drug therapy.
Topics: Amphetamine; Antidepressive Agents; Chlorpromazine; Chlorprothixene; Clinical Trials as Topic; Hallu | 1967 |
27 trials available for haloperidol and Mental Disorders
| Article | Year |
|---|---|
Does early antipsychotic response predict long-term treatment outcome?
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Haloperidol; Hospitalizatio | 2017 |
Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants: A randomized controlled trial.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Antipsychotic Agents; Benzodiazepines; Brief Psyc | 2018 |
Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Brain; Double-Blind Method; Fema | 2008 |
The treatment of challenging behaviour in intellectual disabilities: cost-effectiveness analysis.
Topics: Adult; Aggression; Antipsychotic Agents; Combined Modality Therapy; Cost-Benefit Analysis; Double-Bl | 2009 |
Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Double-Blind Metho | 2011 |
Reducing seclusion through involuntary medication: a randomized clinical trial.
Topics: Adult; Aggression; Antipsychotic Agents; Coercion; Drug Therapy, Combination; Female; Haloperidol; H | 2013 |
Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine.
Topics: Adult; Aggression; Drug Therapy, Combination; Emergency Service, Hospital; Emergency Services, Psych | 2003 |
Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine.
Topics: Antipsychotic Agents; Drug Therapy, Combination; Emergencies; Emergency Service, Hospital; Female; H | 2004 |
Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dyskinesia, Drug-Induced; Follow-Up St | 2004 |
Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Combinations; Emergency Services, Psychiatric; Ha | 2007 |
Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine.
Topics: Adult; Aggression; Antipsychotic Agents; Drug Combinations; Emergency Services, Psychiatric; Haloper | 2007 |
Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial.
Topics: Adult; Aged; Aggression; Antipsychotic Agents; Female; Haloperidol; Humans; Male; Mental Competency; | 2008 |
Haloperidol: a quarter century of experience.
Topics: Aged; Basal Ganglia Diseases; Bipolar Disorder; Clinical Trials as Topic; Dosage Forms; Drug Adminis | 1983 |
A controlled evaluation of psychoeducational family intervention in a rural Chinese community.
Topics: Adolescent; Adult; Aged; Attitude to Health; Caregivers; China; Combined Modality Therapy; Community | 1994 |
Intravenous sedation of involuntary psychiatric patients in New South Wales.
Topics: Adult; Benztropine; Commitment of Mentally Ill; Diazepam; Drug Utilization; Emergency Services, Psyc | 1997 |
Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Child; Cholinergic Antagonist | 1999 |
The behavior therapies: therapeutic breakthrough or latest fad?
Topics: Behavior Therapy; Chronic Disease; Clinical Trials as Topic; Female; Haloperidol; History, 20th Cent | 1976 |
An automated diagnostic process (PDA) in clinical psychopharmacology. An exemplification of its use in a sulpiride versus haloperidol comparative trial.
Topics: Adult; Aged; Clinical Trials as Topic; Diagnosis, Computer-Assisted; Female; Haloperidol; Humans; Ma | 1976 |
Rehabilitation of the chronic patient: experience in the USA.
Topics: Chronic Disease; Clinical Trials as Topic; Female; Haloperidol; Humans; Male; Mental Disorders; Midd | 1976 |
Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study.
Topics: Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Clinical Trials as Topic; Clopenthixol; D | 1989 |
Review of clinical and laboratory experiences with molindone hydrochloride.
Topics: Akathisia, Drug-Induced; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Response Relationshi | 1985 |
Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
Topics: Adult; Aged; Basal Ganglia Diseases; Brain Chemistry; Clinical Trials as Topic; Dopamine; Evaluation | 1972 |
Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
Topics: Adult; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Response Relationship, Drug; Evaluatio | 1973 |
Haloperidol and chlorpromazine: a double-blind cross-over trial and clinical study in children and adolescents.
Topics: Adjustment Disorders; Adolescent; Analysis of Variance; Child; Child Behavior Disorders; Chlorpromaz | 1973 |
The current status of lithium in psychiatry.
Topics: Acute Disease; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Depression; Female; Halop | 1974 |
Drug therapy.
Topics: Amphetamine; Antidepressive Agents; Chlorpromazine; Chlorprothixene; Clinical Trials as Topic; Hallu | 1967 |
A double-blind comparison of haloperidol with perphenazine in acute psychiatric episodes.
Topics: Acute Disease; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Haloperidol; Humans; M | 1969 |
225 other studies available for haloperidol and Mental Disorders
| Article | Year |
|---|---|
Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.
Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Biological Availability; Drug Discovery; El | 2014 |
Two novel mouse models mimicking minor deletions in 22q11.2 deletion syndrome revealed the contribution of each deleted region to psychiatric disorders.
Topics: 22q11 Deletion Syndrome; Animals; Base Sequence; Behavior, Animal; Circadian Rhythm; Conditioning, C | 2021 |
Who Should Implement Force When It's Needed and How Should It Be Done Compassionately?
Topics: Antipsychotic Agents; Drug Administration Routes; Empathy; Ethical Analysis; Haloperidol; Humans; Me | 2021 |
Prevalence and clinical presentation of HIV positive female psychiatric inpatients.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Comorbidity; Cross-Sectional Studie | 2013 |
Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions.
Topics: Animals; Antipsychotic Agents; Biomarkers; Brain; Computational Biology; CpG Islands; DNA Methylatio | 2013 |
A prospective study of high dose sedation for rapid tranquilisation of acute behavioural disturbance in an acute mental health unit.
Topics: Adult; Droperidol; Drug Therapy, Combination; Female; Haloperidol; Humans; Hypnotics and Sedatives; | 2013 |
Comparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Disease Models, Animal; Epi | 2015 |
Examining Huntington's disease patient and informant concordance on frontally mediated behaviors.
Topics: Adult; Aged; Antipsychotic Agents; Awareness; Cognition Disorders; Disease Progression; Female; Fron | 2015 |
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Cross-Sectional Studies; Dose-Re | 2016 |
CYP2D6 *6/*6 genotype and drug interactions as cause of haloperidol-induced extrapyramidal symptoms.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Cytochrome P-450 CYP2D6; Drug Interactions; Gene | 2016 |
Effect of psychotropic drug treatment on sterol metabolism.
Topics: Adult; Animals; Antidepressive Agents; Antipsychotic Agents; Body Mass Index; Cholestadienols; Cloza | 2017 |
Attitudes of patients and family members towards implantable psychiatric medication.
Topics: Adult; Attitude to Health; Clozapine; Cross-Cultural Comparison; Data Collection; Drug Implants; Fam | 2008 |
The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice.
Topics: Analgesics, Opioid; Animals; Antipsychotic Agents; Belgium; Butyrophenones; Drug Industry; Haloperid | 2009 |
[Mental patients and their profile of compliance with psychopharmacological treatment].
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cross-Sectional Studies; Female; Haloperidol; | 2009 |
Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.
Topics: Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Drug Administration Schedule | 2010 |
Interaction of haloperidol plasma level and antipsychotic effect in early phases of acute psychosis treatment.
Topics: Administration, Oral; Adult; Analysis of Variance; Antipsychotic Agents; Female; Haloperidol; Humans | 2010 |
A prospective naturalistic multicentre study of intravenous medications in behavioural emergencies: haloperidol versus flunitrazepam.
Topics: Administration, Intravenous; Adult; Antipsychotic Agents; Drug Therapy, Combination; Electrocardiogr | 2010 |
Characteristics of admissions to a recently opened Psychiatric Emergency Care Centre.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Antipsychotic Agents; Australia; Drug Prescriptions; | 2010 |
[Reaction on 'Antipsychotics and metabolic abnormalities in children and adolescents; a review of the literature and some recommendations'].
Topics: Adolescent; Antipsychotic Agents; Child; Energy Metabolism; Evidence-Based Medicine; Haloperidol; Hu | 2010 |
Lack of association between 71 variations located in candidate genes and response to acute haloperidol treatment.
Topics: Adult; Antipsychotic Agents; Female; Gene Frequency; Genetic Variation; Genome-Wide Association Stud | 2011 |
Use of dolls as a therapeutic intervention: relationship to previous negative behaviors and pro re nata (prn) Haldol use among geropsychiatric inpatients.
Topics: Aged; Female; Geriatric Psychiatry; Haloperidol; Humans; Inpatients; Male; Mental Disorders; Middle | 2011 |
Sedation effects on responsiveness: evaluating the reduction of antipsychotic medication in people with intellectual disability using a conditional probability approach.
Topics: Adult; Aged; Antipsychotic Agents; Behavior Therapy; Combined Modality Therapy; Drug Administration | 2002 |
TREC-Rio trial: a randomised controlled trial for rapid tranquillisation for agitated patients in emergency psychiatric rooms [ISRCTN44153243].
Topics: Brazil; Clinical Protocols; Drug Combinations; Emergency Services, Psychiatric; Ethics, Research; Ha | 2002 |
Re: Chan et al. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 16: 1156 - 1162.
Topics: Alzheimer Disease; Antipsychotic Agents; China; Double-Blind Method; Haloperidol; Humans; Mental Dis | 2002 |
Effects of age and the CYP2D6*10 allele on the plasma haloperidol concentration/dose ratio.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alleles; Analysis of Variance; Cytochrome P-450 CYP2D6; | 2003 |
Effect of CYP2D6 genotypes on the metabolism of haloperidol in a Japanese psychiatric population.
Topics: Adult; Aged; Analysis of Variance; Cytochrome P-450 CYP2D6; Female; Genotype; Haloperidol; Humans; J | 2003 |
Clinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham chorea.
Topics: Adolescent; Antibiotic Prophylaxis; Antipsychotic Agents; Brain; Child; Chorea; Female; Follow-Up St | 2003 |
Haloperidol plasma concentration in Japanese psychiatric subjects with gene duplication of CYP2D6.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Gene Duplication | 2003 |
[Study & clinical trial of R 1625 or haloperidol, a new neuroleptic & so-called neurodysleptic agent].
Topics: Antipsychotic Agents; Electroconvulsive Therapy; Haloperidol; Humans; Hypnotics and Sedatives; Menta | 1959 |
The effect of R-1625 (Haloperidol) in mental syndromes: a multiblind study.
Topics: Anesthesia; Electroconvulsive Therapy; Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psych | 1960 |
[Contribution to the study of the use of haloperidol].
Topics: Electroconvulsive Therapy; Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psychosurgery; Ps | 1961 |
[Contribution to the study of R-1625 or haloperidol in chronic psychoses or behavior disorders of certain mentally degenerated patients].
Topics: Anesthesia; Chronic Disease; Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psychopharmacol | 1960 |
[Haloperidol in maintenance doses].
Topics: Electroconvulsive Therapy; Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psychosurgery; Ps | 1960 |
[Clinical experiences with haldol (haloperidol "Jansen"].
Topics: Electroconvulsive Therapy; Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psychosurgery; Ps | 1961 |
[Haloperidol in the treatment of delirium tremens].
Topics: Alcohol Withdrawal Delirium; Anesthesia; Haloperidol; Humans; Hypnotics and Sedatives; Mental Disord | 1961 |
[Haloperidol in states of manic excitation (apropos of 10 cases)].
Topics: Anesthesia; Bipolar Disorder; Haloperidol; Humans; Hypnotics and Sedatives; Mental Disorders; Psycho | 1961 |
[Experience with haloperidol therapy].
Topics: Electroconvulsive Therapy; Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psychosurgery; Ps | 1960 |
[Haloperidol (R-1625) in psychiatric practice (its therapeutic results obtained in 42 cases of mental diseases)].
Topics: Haloperidol; Humans; Mental Disorders; Psychopharmacology; Psychotic Disorders | 1960 |
[The therapy of psychoses with haloperidol].
Topics: Electroconvulsive Therapy; Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psychosurgery; Ps | 1960 |
[Clinical contribution to therapy with Haloperidol].
Topics: Electroconvulsive Therapy; Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psychosurgery; Ps | 1961 |
[Clinical tests with haldol in long-term schizophrenia and acute manic states].
Topics: Anesthesia; Bipolar Disorder; Haloperidol; Humans; Hypnotics and Sedatives; Mental Disorders; Psycho | 1961 |
[First results of the treatment of 60 cases of mental disorders with a new neuroleptic agent, haloperidol (R 1625)].
Topics: Antipsychotic Agents; Electroconvulsive Therapy; Haloperidol; Hypnotics and Sedatives; Mental Disord | 1960 |
[Clinical aspects in 55 cases treated with haloperidol].
Topics: Anesthesia; Haloperidol; Hypnotics and Sedatives; Mental Disorders | 1960 |
[Results of 6 months of clinical experimentation with R 1625 (haloperidol)].
Topics: Anesthesia; Haloperidol; Hypnotics and Sedatives; Mental Disorders | 1960 |
[A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses].
Topics: Antipsychotic Agents; Haloperidol; Mental Disorders; Phenothiazines; Psychosurgery; Psychotic Disord | 1960 |
[Haloperidol and chemotherapy of psychoses].
Topics: Electroconvulsive Therapy; Haloperidol; Humans; Mental Disorders; Psychopharmacology; Psychotherapy; | 1960 |
[The action of haloperidol in psychoses].
Topics: Anesthesia; Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psychotic Disorders | 1960 |
[Report on the neuropsycho-pharmacological activity of haloperidol (R 1625)].
Topics: Anesthesia; Haloperidol; Hypnotics and Sedatives; Mental Disorders | 1960 |
Clinical trials of R 1625.
Topics: Anesthesia; Haloperidol; Hypnotics and Sedatives; Mental Disorders | 1960 |
[1st results of the therapeutic use of haloperidol in child neuropsychiatry].
Topics: Anesthesia; Child; Haloperidol; Hypnotics and Sedatives; Infant; Mental Disorders; Neuropsychiatry | 1961 |
[Clinical observations on the treatment of psychoses with haloperidol].
Topics: Electroconvulsive Therapy; Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psychosurgery; Ps | 1961 |
The treatment of mania with Haloperidol ('Serenace').
Topics: Anesthesia; Bipolar Disorder; Haloperidol; Humans; Hypnotics and Sedatives; Mental Disorders; Psycho | 1962 |
[Effect of Haloperidol on behavior disorders in the epileptic child].
Topics: Anesthesia; Child; Epilepsy; Haloperidol; Humans; Hypnotics and Sedatives; Infant; Mental Disorders | 1962 |
[Experiences with Haloperidol].
Topics: Haloperidol; Humans; Intellectual Disability; Mental Disorders | 1962 |
[Study of the therapeutic effects of a butyrophenone (R-1625--Haloperidin--haloperidol) in psychoses].
Topics: Butyrophenones; Haloperidol; Humans; Mental Disorders; Psychotic Disorders | 1963 |
[Haioperidol, an emergency neuroleptic, on the open ward].
Topics: Antipsychotic Agents; Emergencies; Haloperidol; Humans; Mental Disorders | 1962 |
[Clinical experimentation with haloperidol (R 1625) in psychiatry].
Topics: Haloperidol; Humans; Mental Disorders; Psychiatry | 1962 |
[Clinical experience with Haloperidol treatment of long-term patients].
Topics: Haloperidol; Humans; Mental Disorders; Psychotic Disorders | 1963 |
[Acute alcoholic psychoses. Treatmetn by haloperidol].
Topics: Haloperidol; Humans; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders | 1962 |
[Clinical trials of a new neuroleptic of the butyrophenone group].
Topics: Antipsychotic Agents; Butyrophenones; Haloperidol; Humans; Mental Disorders | 1963 |
[Differences in biological reactivity to haloperiodol in 2 groups of psychotics, American and European].
Topics: Ethnicity; Haloperidol; Humans; Mental Disorders; Psychotic Disorders; United States | 1962 |
THE USE OF HALOPERIDOL (SERENASE (R)) IN CHLORPROTIXEN RESISTANT PATIENTS.
Topics: Accommodation, Ocular; Adolescent; Antisocial Personality Disorder; Bipolar Disorder; Chlorprothixen | 1963 |
OBSERVATIONS ON USE OF HALOPERIDOL FOLLOWING 3 YEARS' EXPERIENCE.
Topics: Haloperidol; Humans; Mental Disorders; Psychotic Disorders | 1963 |
[OUR EXPERIENCES WITH A NEW MAJOR NEUROLEPTIC: HALOPERIDOL].
Topics: Antipsychotic Agents; Bipolar Disorder; Epilepsy; Haloperidol; Humans; Mental Disorders; Psychoses, | 1963 |
[TREATMENT OF ACUTE COMPLICATIONS OF CHRONIC ALCOHOLISM WITH R-1625 (HALOPERIDOL)].
Topics: Alcoholism; Haloperidol; Humans; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders | 1963 |
[URINARY STEROIDS AND PSYCHOTROPIC CHEMOTHERAPY].
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Chlorpromazine; Haloperidol; Imipramine; Iproniazid; Menta | 1963 |
[CLINICAL EXPERIENCE WITH A NEW NEUROLEPTIC: R 1625 OR HALOPERIDOL].
Topics: Antipsychotic Agents; Argentina; Haloperidol; Mental Disorders; Pharmacology; Psychopharmacology; St | 1963 |
HALOPERIDOL: A CONTROLLED CLINICAL TRIAL IN CHRONIC DISTURBED PSYCHOTIC PATIENTS.
Topics: Haloperidol; Humans; Mental Disorders; Placebos; Psychotic Disorders; Toxicology | 1964 |
[ON PSYCHOSES INDUCED BY CARDIAC DECOMPENSATION. THERAPEUTIC FINDINGS AND NOTES].
Topics: Haloperidol; Heart Failure; Humans; Mental Disorders; Psychotic Disorders | 1963 |
[THE TREATMENT OF MANIAS AND MANIC STATES WITH HALOPERIDOL].
Topics: Bipolar Disorder; Haloperidol; Humans; Mental Disorders; Psychotic Disorders | 1964 |
[CLINICAL ASPECTS OF HALOPERIDOL].
Topics: Dementia; Geriatrics; Haloperidol; Injections, Intramuscular; Mental Disorders; Neurotic Disorders; | 1964 |
[CLINICO-PSYCHIATRIC EXPERIMENTATION WITH HALOPERIDOL].
Topics: Biomedical Research; Haloperidol; Mental Disorders; Movement Disorders; Salivation; Sleep Initiation | 1964 |
[CLINICAL EXPERIENCES WITH HALOPERIDOL (SERENASE)].
Topics: Bipolar Disorder; Chlorpromazine; Chorea; Dementia; Depressive Disorder, Major; Epilepsy; Haloperido | 1964 |
DEPRESSIVE AND MANIC PSYCHOSES AND ALLIED DISORDERS.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Barbiturates; Bipolar Disorder; Depression; Electr | 1964 |
DIFFERENTIAL INTER-DRUG ANALYSIS: A PRELIMINARY STUDY.
Topics: Aggression; Biomedical Research; Chlorpromazine; Delusions; Haloperidol; Humans; Mental Disorders; P | 1964 |
[THE BUTYROPHENONE DERIVATIVES].
Topics: Alcoholism; Antipsychotic Agents; Haloperidol; Humans; Intellectual Disability; Ketones; Mental Diso | 1964 |
HALOPERIDOL IN THE PSYCHIATRIC DISORDERS OF OLD AGE.
Topics: Biomedical Research; Dementia; Geriatrics; Haloperidol; Intracranial Arteriosclerosis; Mental Disord | 1964 |
[MODIFICATIONS OF THE EEG DUE TO PSYCHOPHARMACOLOGICAL TREATMENT. LONG-TERM STUDIES ON MENTAL PATIENTS].
Topics: Bemegride; Chlormethiazole; Chlorpromazine; Electroencephalography; Haloperidol; Humans; Hypnotics a | 1963 |
[HUNTINGTON'S CHOREA, HUMOR DISORDERS WITH MANIC MANIFESTATIONS, BENEFICIAL EFFECTS OF HALOPERIDOL (FLUOROPHENYLPIPERIDINOBUTYROPHENONE). ABSENCE OF THE THERAPEUTIC AKINETO-HYPERTONIC SYNDROME].
Topics: Bipolar Disorder; Chlorpromazine; Chorea; Electroencephalography; Electromyography; Haloperidol; Hum | 1964 |
[COGENTINE (BTMS) IN THE TREATMENT OF NEUROLEPTIC SYNDROMES].
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Delirium; Depression; Hallucinations; Halope | 1964 |
[CLINICO-THERAPEUTIC TRIALS WITH DIPIPERON, A NEW BUTYROPHENONE SERIES DERIVATIVE].
Topics: Butyrophenones; Depression; Haloperidol; Humans; Hypnotics and Sedatives; Mental Disorders; Psychoti | 1964 |
[CONTRIBUTION TO THE STUDY OF A NEURODYSLEPTIC SYNDROME IN THE COURSE OF HALOPERIDOL THERAPY].
Topics: Antisocial Personality Disorder; Drug Therapy; Extrapyramidal Tracts; Haloperidol; Mental Disorders; | 1964 |
[TREATMENT OF CHRONIC PSYCHOSES WITH HALOPERIDOL (R 1625)].
Topics: Bipolar Disorder; Drug Therapy; Haloperidol; Humans; Mental Disorders; Movement Disorders; Psychotic | 1964 |
[HUNTINGTON'S CHOREA, TEMPERAMENT DISORDERS OF MANIAC EXPRESSION. BENEFICIAL EFFECTS OF HALOPERIDOL (FLUORO-PHENYL-PIPERIDINE BUTYROPHENONE). ABSENCE OF THE THERAPEUTIC AKINETO-HYPERTONIC SYNDROME].
Topics: Bipolar Disorder; Butyrophenones; Chorea; Drug Therapy; Electromyography; Haloperidol; Humans; Hunti | 1964 |
CHANGES IN SERUM PROTEINS AND CEREBROSPINAL FLUID PROTEINS DURING PHARMACOTHERAPY OF PSYCHOSES.
Topics: Alcoholism; Bipolar Disorder; Blood Proteins; Cerebrospinal Fluid Proteins; Chlorpromazine; Drug The | 1964 |
TOURETTE'S DISEASE: SYMPTOMATIC RELIEF WITH HALOPERIDOL.
Topics: Child; Drug Therapy; Haloperidol; Humans; Mental Disorders; Tics; Tourette Syndrome; Tranquilizing A | 1964 |
[CLINICAL IMPRESSIONS DRAWN FROM 80 BEN-PERIDOL TREATMENTS].
Topics: Drug Therapy; Haloperidol; Humans; Mental Disorders | 1965 |
[HALOPERIDOL IN MENTAL DISEASES; CLINICAL CONTRIBUTION].
Topics: Drug Therapy; Haloperidol; Humans; Mental Disorders; Psychotic Disorders | 1965 |
[Clinical study of R 1625 (haloperidol)].
Topics: Anesthesia; Haloperidol; Hypnotics and Sedatives; Mental Disorders | 1960 |
[Clinical experimentation with haloperidol (R-1625) in psychiatry].
Topics: Anesthesia; Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psychiatry | 1960 |
[Clinical experimentation with R 1625 (haloperidol)].
Topics: Anesthesia; Haloperidol; Hypnotics and Sedatives; Mental Disorders | 1960 |
[Observations on the use of R 1625].
Topics: Anesthesia; Haloperidol; Hypnotics and Sedatives; Mental Disorders | 1960 |
[Clinical experiences with the neuroleptic haloperidol (R 1625)].
Topics: Anesthesia; Antipsychotic Agents; Haloperidol; Hypnotics and Sedatives; Mental Disorders | 1960 |
[Clinical experimentation with haloperidol].
Topics: Anesthesia; Haloperidol; Hypnotics and Sedatives; Mental Disorders | 1960 |
[Clinical study of the action of R 1625 in moderate doses in psychiatry].
Topics: Haloperidol; Hypnotics and Sedatives; Mental Disorders; Psychiatry; Tranquilizing Agents | 1959 |
[Preliminary observations on the therapeutic effect of R 1625 (haloperidol) and on its electroencephalographic effects in rabbits].
Topics: Anesthesia; Animals; Electroencephalography; Haloperidol; Hypnotics and Sedatives; Mental Disorders; | 1960 |
[Note on the use of R 1625 in a group of acute psychoses of alcoholic origin].
Topics: Haloperidol; Humans; Hypnotics and Sedatives; Mental Disorders; Psychoses, Alcoholic; Psychotic Diso | 1961 |
[Haloperidol treatment of psychotic mentally deficient patients].
Topics: Electroconvulsive Therapy; Haloperidol; Hypnotics and Sedatives; Intellectual Disability; Mental Dis | 1962 |
Effects of smoking and cytochrome P450 2D6*10 allele on the plasma haloperidol concentration/dose ratio.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Analysis of Variance; Cytochrome P-450 CYP2D6; Dose-Respons | 2003 |
Altered neurotensin mrna expression in mice lacking the dopamine transporter.
Topics: Amphetamine; Animals; Brain; Dopamine Agents; Dopamine Antagonists; Dopamine Plasma Membrane Transpo | 2004 |
Relationship between haloperidol plasma concentration, debrisoquine metabolic ratio, CYP2D6 and CYP2C9 genotypes in psychiatric patients.
Topics: Adult; Aged; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 C | 2004 |
Treatment of acute self-aggressive behaviour in a captive gorilla (Gorilla gorilla gorilla).
Topics: Aggression; Animals; Antipsychotic Agents; Anxiety; Ape Diseases; Female; Gorilla gorilla; Haloperid | 2004 |
Abnormal behavior in children with temporal lobe epilepsy and ganglioglioma.
Topics: Anticonvulsants; Antipsychotic Agents; Brain Neoplasms; Child; Electroencephalography; Epilepsy, Tem | 2004 |
[The value of publishing negative results from a randomized controlled trial: the Rosenheck's study].
Topics: Benzodiazepines; Haloperidol; Humans; Mental Disorders; Olanzapine; Publication Bias; Randomized Con | 2004 |
Neurobehavioral changes associated with bilateral caudate nucleus infarctions.
Topics: Basal Ganglia Cerebrovascular Disease; Caudate Nucleus; Cerebral Cortex; Cerebral Infarction; Delusi | 2005 |
Limitations of rapid tranquillisation trial.
Topics: Antipsychotic Agents; Central Nervous System Depressants; Drug Therapy, Combination; Haloperidol; Hu | 2005 |
Stability of tramadol and haloperidol for continuous subcutaneous infusion at home.
Topics: Analgesics, Opioid; Antipsychotic Agents; Chemical Phenomena; Chemistry, Physical; Drug Combinations | 2005 |
Effect of antipsychotics on mortality in elderly patients with dementia: a 1-year prospective study in a nursing home.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Confidence Intervals; Dementia, Va | 2005 |
[Comparison of emergency psychiatric services in Tokyo and Chiba prefecture].
Topics: Drug Utilization; Emergency Services, Psychiatric; Flunitrazepam; Haloperidol; Hospitalization; Hosp | 2005 |
Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Topics: Aged; Antipsychotic Agents; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Haloper | 2007 |
Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain Edema; Fatal Outcome; Fluphenazine; Haloperidol; | 2007 |
Three cases of schizophrenia for which olanzapine was effective after early acute phase.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Foll | 2008 |
Haloperidol and blood cholesterol: a cross-sectional survey in a psychiatric hospital.
Topics: Age Factors; Body Height; Body Weight; Cholesterol; Female; Haloperidol; Humans; Male; Menopause; Me | 1967 |
Lithium/haloperidol combinations and brain damage.
Topics: Brain; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Mental Disorders; Middle Aged; Mood | 1982 |
Lithium/haloperidol combinations and brain damage.
Topics: Brain; Drug Combinations; Drug Synergism; Haloperidol; Humans; Lithium; Mental Disorders | 1982 |
[Therapeutic profile of haloperidol].
Topics: Agranulocytosis; Antipsychotic Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug | 1980 |
Dissimilar dosing with high-potency and low-potency neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Drug Utilization; F | 1984 |
Therapeutic drug monitoring of psychotropic drugs in children.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Child; Child | 1983 |
[Huntington chorea: report of 16 cases].
Topics: Adult; Aged; Brain Diseases; Chlorpromazine; Dementia; Diagnosis, Differential; Female; gamma-Aminob | 1983 |
Adverse drug reactions. An epidemiological study at psychiatric hospitals.
Topics: Adult; Amitriptyline; Drug Evaluation; Female; Germany, West; Haloperidol; Hospitals, Psychiatric; H | 1984 |
Monitoring of haloperidol serum levels and it's clinical significance.
Topics: Administration, Oral; Basal Ganglia Diseases; Dosage Forms; Haloperidol; Humans; Intestinal Absorpti | 1984 |
Tourette's syndrome: update.
Topics: Adolescent; Child; Child, Preschool; Diagnosis, Differential; Diagnostic Errors; Diseases in Twins; | 1984 |
Haloperidol -- its use in children.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Dose-Response Relationship, Drug; Haloperidol; | 1981 |
Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
Topics: Adolescent; Adult; Age Factors; Aged; Antiparkinson Agents; Basal Ganglia Diseases; Drug Therapy, Co | 1982 |
[Treatment of outpatients with high doses of haloperidol].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antiparkinson Agents; Basal Ganglia Diseases; Bipolar Diso | 1981 |
Regional cerebral blood flow measurements by 133Xe-inhalation: methodology and applications in neuropsychology and psychiatry.
Topics: Adult; Affective Symptoms; Aged; Alcoholism; Cerebrovascular Circulation; Computers; Dementia; Femal | 1980 |
Haloperidol plasma level monitoring in psychiatric patients.
Topics: Biological Availability; Child; Drug Resistance; Haloperidol; Humans; Mental Disorders | 1980 |
Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome?
Topics: Adult; Antipsychotic Agents; Brain; Cell Death; Cocaine; Diagnosis, Differential; Diazepam; Female; | 1995 |
Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cornea; Corneal Diseases; Female; Follow-Up Studies; Ha | 1993 |
[Successful electroconvulsive therapy in a pregnant woman with neuroleptic malignant syndrome].
Topics: Adult; Electroconvulsive Therapy; Female; Haloperidol; Humans; Infant, Newborn; Mental Disorders; Ne | 1994 |
Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects.
Topics: Adult; Brain; Cerebellum; Cerebral Cortex; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Haloperido | 1994 |
Delusions of transformation of the self.
Topics: Adult; Delusions; Ego; Female; Haloperidol; Humans; Male; Mental Disorders; Middle Aged; Psychiatric | 1993 |
Neuropsychiatric aspects of Sydenham's chorea: a case report.
Topics: Adult; Cephalexin; Chorea; Electroencephalography; Female; Haloperidol; Humans; Mental Disorders; Ph | 1993 |
Rapid stabilization at home.
Topics: Administration, Oral; Antiparkinson Agents; Antipsychotic Agents; Benztropine; Drug Therapy, Combina | 1996 |
Neuroleptic-induced dysphagia.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Deglutition Disorders; Fluoroscopy; Haloperidol; Huma | 1997 |
Hoarding symptoms in patients on a geriatric psychiatry inpatient unit.
Topics: Aged; Antipsychotic Agents; Chi-Square Distribution; Compulsive Behavior; Female; Haloperidol; Human | 1997 |
Comparison of two high-performance liquid chromatographic methods for monitoring plasma concentrations of haloperidol and reduced haloperidol.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Calibration; Chromatography, High Pressure Liquid | 1998 |
Conventional psychotropic-induced tremor extinguished by olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Fluphenazine; Haloperidol; Humans; Male; Menta | 1998 |
Body weight and leptin plasma levels during treatment with antipsychotic drugs.
Topics: Adipose Tissue; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body W | 1999 |
Cardiotoxicity associated with use of intravenous haloperidol.
Topics: Antipsychotic Agents; Arrhythmias, Cardiac; Haloperidol; Humans; Injections, Intravenous; Mental Dis | 1999 |
Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients.
Topics: Aged; Antipsychotic Agents; Chi-Square Distribution; Dyskinesia, Drug-Induced; Female; Haloperidol; | 1999 |
Emergency psychiatry: contemporary practices in managing acutely violent patients in 20 psychiatric emergency rooms.
Topics: Acute Disease; Antipsychotic Agents; Drug Administration Schedule; Emergency Services, Psychiatric; | 1999 |
[Mental disorders in acute neuroleptic poisoning].
Topics: Acute Disease; Adult; Age Distribution; Antipsychotic Agents; Chlorpromazine; Clozapine; Female; Hal | 1999 |
Current practices in managing acutely disturbed patients at three hospitals in Rio de Janeiro-Brazil: a prevalence study.
Topics: Aggression; Benzodiazepines; Brazil; Clinical Protocols; Drug Combinations; Drug Utilization; Emerge | 2002 |
Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Humans; Male; Mental Disorde | 2002 |
Population pharmacokinetics of haloperidol using routine clinical pharmacokinetic data in Japanese patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Antiparkinson Agents; Antipsychotic Age | 2002 |
[An experimental study of the spectrum of individual psychotropic activity of clozapine (Leponex)].
Topics: Animals; Antipsychotic Agents; Cats; Clozapine; Diazepam; Dibenzazepines; Disease Models, Animal; Ha | 1975 |
Drugs for psychiatric disorders.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; | 1976 |
High-dose treatment with neuroleptics in the acute phase of mental disease.
Topics: Antipsychotic Agents; Flupenthixol; Fluphenazine; Haloperidol; Humans; Mental Disorders; Perphenazin | 1976 |
[Mental complications of neuroleptic drugs. Confusional oneiric states].
Topics: Antipsychotic Agents; Cognition Disorders; Confusion; Female; Haloperidol; Humans; Mental Disorders; | 1978 |
Behavioral toxicity. Neuroleptic-induced paradoxical behavioral toxicity in young borderline schizoprenics.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Haloperidol; Humans; Male; Mental Disorders; Pe | 1979 |
Clinical significance of monitoring plasma levels of psychotropic drugs.
Topics: Adult; Child; Chronic Disease; Clomipramine; Haloperidol; Humans; Mental Disorders; Parasympatholyti | 1979 |
Drug interaction between haloperidol and methyldopa.
Topics: Aged; Aggression; Drug Interactions; Female; Haloperidol; Humans; Mental Disorders; Methyldopa | 1979 |
Management of disturbed patients: an alternative to the use of mechanical restraints.
Topics: Amobarbital; Attitude of Health Personnel; Chlorpromazine; Diazepam; Haloperidol; Hospitals, Psychia | 1978 |
[Disinhibition and its risks].
Topics: Adjustment Disorders; Alcoholism; Antidepressive Agents; Depressive Disorder, Major; Haloperidol; Hu | 1978 |
Serum dopamine-beta-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol.
Topics: Depression; Dextroamphetamine; Dopamine beta-Hydroxylase; Haloperidol; Humans; Mental Disorders; Sch | 1976 |
The role of drug therapy in emergency psychiatry.
Topics: Chlorpromazine; Diazepam; Emergencies; Haloperidol; Humans; Mental Disorders | 1977 |
The role of drug therapy in emergency psychiatry.
Topics: Barbiturates; Chlorpromazine; Diazepam; Emergencies; Haloperidol; Humans; Mental Disorders; Middle A | 1977 |
Importance of dopamine metabolism for clinical effects and side effects of neuroleptics.
Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia Diseases; Chlorpromazine; Dopamine; Dopamine Antago | 1976 |
Haloperidol update: 1975.
Topics: Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Haloperidol; Humans; Mental Disorders; Parkinson D | 1976 |
The rapid control of the acute patient by haloperidol.
Topics: Acute Disease; Age Factors; Body Weight; Female; Haloperidol; Humans; Male; Mental Disorders; Sex Fa | 1976 |
Adverse reactions in treatment with lithium carbonate and haloperidol.
Topics: Affective Symptoms; Bipolar Disorder; Drug Synergism; Female; Fever; Haloperidol; Humans; Lithium; M | 1976 |
Haloperidol; a useful psychiatric drug.
Topics: Haloperidol; Humans; Mental Disorders | 1976 |
Drug-induced dystonia.
Topics: Adjustment Disorders; Adult; Basal Ganglia Diseases; Chlorpromazine; Chlorprothixene; Female; Fluphe | 1975 |
Editorial: Physostigmine: value in treatment of central toxic effects of anti-cholinergic drugs.
Topics: Amitriptyline; Benztropine; Brain; Doxepin; Haloperidol; Humans; Injections, Intramuscular; Mental D | 1975 |
Letter: An unusual adverse reaction with butyrophenone therapy.
Topics: Adult; Female; Haloperidol; Humans; Mental Disorders; Urination Disorders | 1975 |
Physicians' acceptance of behavioral treatments and pharmacotherapy for behavioral disturbances in older adults.
Topics: Aged; Analysis of Variance; Attitude of Health Personnel; Behavior Therapy; Female; Haloperidol; Hum | 1992 |
Haloperidol metabolism in psychiatric patients: importance of glucuronidation and carbonyl reduction.
Topics: Adolescent; Adult; Alcohol Oxidoreductases; Chromatography, High Pressure Liquid; Erythrocytes; Fema | 1992 |
Haloperidol and reduced haloperidol in saliva and blood.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Erythrocytes; Female; Haloperidol; Humans; Male; | 1992 |
Absence of detectable immunoreactive alpha melanocyte stimulating hormone in plasma in various types of Cushing's disease.
Topics: Addison Disease; Adrenocorticotropic Hormone; alpha-MSH; Animals; Cushing Syndrome; Dogs; Haloperido | 1991 |
Our experience with incisive neuroleptic drugs in child psychiatry.
Topics: Antipsychotic Agents; Autistic Disorder; Child; Haloperidol; Humans; Mental Disorders; Obsessive-Com | 1991 |
[Judicial aspects of treatment of incompetent psychiatric patients who categorically refuse treatment].
Topics: Adult; Combined Modality Therapy; Commitment of Mentally Ill; Dangerous Behavior; Expert Testimony; | 1991 |
Neurologic approach to drug-induced movement disorders: a study of 125 patients.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amitriptyline; Antipsychotic Agents; Chorea | 1990 |
Hypothermia in the summer.
Topics: Adult; Aged; Alcoholism; Emergencies; Haloperidol; Humans; Hypothermia; Male; Mental Disorders; Nutr | 1991 |
Reduced haloperidol/haloperidol ratios in plasma: polymorphism in Japanese psychiatric patients.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Japan; Male; | 1990 |
[Maternal haloperidol effects on pregnancy and development of the children].
Topics: Adult; Child Development; Child, Preschool; Female; Fetus; Haloperidol; Humans; Infant, Newborn; Lab | 1990 |
Longisectional interaction structure analysis (LISA) in psychopharmacology and developmental psychopathology.
Topics: Adolescent; Child; Developmental Disabilities; Drug Evaluation; Haloperidol; Humans; Longitudinal St | 1985 |
The dangerous patient.
Topics: Adult; Aggression; California; Confidentiality; Dangerous Behavior; Forensic Medicine; Haloperidol; | 1989 |
Haloperidol prescribing practices in the general hospital.
Topics: Aged; Female; Haloperidol; Hospitals, General; Humans; Male; Mental Disorders; Middle Aged; Neurocog | 1989 |
[The plasma levels of haloperidol and reduced haloperidol in Japanese psychiatric patients].
Topics: Adolescent; Adult; Aged; Asian People; Chromatography, High Pressure Liquid; Dose-Response Relations | 1989 |
The psychiatric intensive care unit.
Topics: Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Australia; Critical Care; Female; Halop | 1985 |
Interpatient variations in antipsychotic therapy.
Topics: Age Factors; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationshi | 1985 |
Neuroleptic blood levels and clinical response.
Topics: Antipsychotic Agents; Chlorpromazine; Chromatography, Gas; Erythrocytes; Haloperidol; Humans; Mental | 1986 |
Drug-induced dystonia in young and elderly patients.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Chlorpromazine; Dystonia; Female; Fluphenazine; Halo | 1988 |
The psychiatric acute observation unit in a general hospital.
Topics: Adolescent; Adult; Aged; Chlorpromazine; Combined Modality Therapy; Emergency Services, Psychiatric; | 1988 |
More than mere shots.
Topics: Chronic Disease; Communication; Fluphenazine; Haloperidol; Humans; Mental Disorders; Patient Care Te | 1988 |
Decreased extrapyramidal symptoms with intravenous haloperidol.
Topics: Administration, Oral; Aged; Basal Ganglia Diseases; Female; Haloperidol; Humans; Injections, Intrave | 1987 |
Exacerbation of tardive dyskinesia by Joseph disease.
Topics: Aged; Brain Diseases; Cerebellar Ataxia; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Ment | 1986 |
The clinical use of psychotherapeutic drugs in the elderly.
Topics: Aged; Aging; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety; Benzodiazepi | 1974 |
Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Depression; Dih | 1974 |
[Differential diagnosis of acute extrapyramidal motor disorders in children. A case study].
Topics: Acute Disease; Adolescent; Basal Ganglia Diseases; Diagnosis, Differential; Female; Haloperidol; Hep | 1974 |
Psychiatric aspects of disseminated lupus erythematosus in Hong Kong Chinese--report of three cases.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Amitriptyline; Chlorpromazine; Epilepsy | 1971 |
[Value of association of propericiazine with haloperidol, or thioproperazine, or prochlorperazine, in the treatment of some psychoses].
Topics: Adolescent; Adult; Female; Haloperidol; Humans; Mental Disorders; Middle Aged; Phenothiazines; Proch | 1971 |
[Study of extrapyramidal manifestations induced by neuroleptics].
Topics: Antiparkinson Agents; Chlorpromazine; Drug Synergism; Extrapyramidal Tracts; Fluphenazine; Haloperid | 1972 |
The organic brain syndrome.
Topics: Alcoholic Intoxication; Attention; Chlordiazepoxide; Delirium; Haloperidol; Humans; Hydrocephalus; M | 1974 |
Psychotropic drugs in old age.
Topics: Age Factors; Aged; Blood Pressure; Chlorpromazine; Female; Haloperidol; Humans; Hypotension; Male; M | 1973 |
Haloperidol: fifteen years of clinical experience.
Topics: Antiemetics; Basal Ganglia Diseases; Bipolar Disorder; Female; Haloperidol; Humans; Mental Disorders | 1972 |
Management of the psychogeriatric patient.
Topics: Aged; Aging; Female; Haloperidol; Humans; Male; Mental Disorders | 1973 |
Antagonism of guanethidine by chlorpromazine.
Topics: Blood Pressure; Chlorpromazine; Drug Interactions; Female; Guanethidine; Haloperidol; Humans; Hypert | 1973 |
[Oral droperidol in psychiatric therapy].
Topics: Administration, Oral; Adolescent; Adult; Aged; Droperidol; Drug Evaluation; Drug Tolerance; Female; | 1974 |
[Case of psychic disorders in hepatic porphyria].
Topics: Adult; Female; Haloperidol; Humans; Liver Diseases; Mental Disorders; Porphyrias; Vitamin B Complex | 1972 |
[Priapisms during neuroleptic drug administration (3 cases)].
Topics: Adult; Chlorpromazine; Haloperidol; Humans; Male; Mental Disorders; Methotrimeprazine; Priapism; Tra | 1972 |
Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia.
Topics: Aged; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Facial Muscles; Female; Haloperidol; Humans; | 1971 |
Analytical and pharmacokinetic studies on butyrophenones.
Topics: Adipose Tissue; Administration, Oral; Animals; Behavior, Animal; Brain; Butyrophenones; Chromatograp | 1971 |
[A preventive and curative method for mental or psychosomatic periodic attacks].
Topics: Adult; Benperidol; Female; Haloperidol; Humans; Lithium; Male; Mental Disorders; Middle Aged; Period | 1971 |
[Psychopharmacological agents in treatment of psychiatric emergencies].
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Dementia; Diazepam; Haloperidol; Humans; Hypnotics | 1971 |
[Course of body temperature during injection therapy with neuroleptics. Statistical evaluation of data from a retrospective study].
Topics: Body Temperature; Chlorpromazine; Chlorprothixene; Clopenthixol; Dibenzothiazepines; Electroconvulsi | 1971 |
The management of excitement in a general hospital psychiatric ward by high dosage haloperidol.
Topics: Administration, Oral; Adult; Aggression; Evaluation Studies as Topic; Female; Haloperidol; Hospitals | 1971 |
Haloperidol--Haldol.
Topics: Haloperidol; Humans; Mental Disorders; Nursing | 1967 |
Clinical dangers of psychological theorizing. The Gilles de la Tourette syndrome.
Topics: Compulsive Behavior; Diagnosis, Differential; Diagnostic Errors; Haloperidol; Humans; Iatrogenic Dis | 1971 |
[Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
Topics: Adolescent; Adult; Aged; Butyrophenones; Female; Haloperidol; Humans; Male; Mental Disorders; Middle | 1967 |
Results of trifluperidol therapy.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Butyrophenones; Fluorine; Haloperidol; Humans; Menta | 1969 |
Treating disturbed adolescents with haloperidol (haldol).
Topics: Adolescent; Adolescent Psychiatry; Haloperidol; Humans; Mental Disorders | 1969 |
Pink spot--is it a drug artefact?
Topics: Amitriptyline; Amobarbital; Chlorpromazine; Chromatography; Haloperidol; Humans; Mental Disorders; P | 1970 |
The present status of psychotropic drugs.
Topics: Antidepressive Agents; Chlormethiazole; Diazepam; Dibenzazepines; Fluphenazine; Haloperidol; Humans; | 1970 |
[C-reactive protein content of the cerebrospinal fluid and blood serum in mental disorders].
Topics: Adult; C-Reactive Protein; Chlorpromazine; Epilepsy; Haloperidol; Humans; Male; Mental Disorders; Mi | 1970 |
Clinical experiences with the application of haloperidol to mental patients.
Topics: Adolescent; Adult; Aged; Female; Haloperidol; Humans; Injections, Intravenous; Mental Disorders; Mid | 1967 |
[Changes in habituation of the alpha rhythm arrest reaction in humans under the effect of chlorpromazine and haloperidol].
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Alcoholism; Auditory Threshold; Cerebral Cortex; | 1967 |
[On the treatment of psycopath-like states in children with psychotropic drugs after infectious and traumatic disorders of the central nervous system].
Topics: Adolescent; Antidepressive Agents; Antisocial Personality Disorder; Brain Diseases; Brain Injuries; | 1967 |
[Clinical experiences with haloperidol in mental patients].
Topics: Adolescent; Adult; Aged; Female; Haloperidol; Humans; Mental Disorders; Middle Aged | 1968 |
Evaluation of a new antipsychotic agent--haloperidol (haldol).
Topics: Bipolar Disorder; Haloperidol; Humans; Mental Disorders; Schizophrenia | 1968 |
[Haloperidol and methylperidol].
Topics: Butyrophenones; Haloperidol; Humans; Mental Disorders; Tranquilizing Agents | 1968 |
Single daily doses of neuroleptic drugs.
Topics: Chlorpromazine; Chlorprothixene; Chronic Disease; Dosage Forms; Fluphenazine; Haloperidol; Humans; M | 1969 |
[Results of use of haloperidol in a medicopedagogical institution].
Topics: Adolescent; Child; Child Behavior Disorders; Female; Haloperidol; Humans; Male; Mental Disorders | 1965 |
[Haloperidol in mental patient treatment].
Topics: Female; Haloperidol; Humans; Male; Mental Disorders | 1966 |